POLARx Post Approval Study (POLARx PAS)
NCT: NCT06170606 · ACTIVE_NOT_RECRUITING
NCT IDNCT06170606
StatusACTIVE_NOT_RECRUITING
Start Date2024-06-28
Completion2029-05
Brief Summary
To collect clinical data on safety, effectiveness and procedural success of Boston Scientific's Cardiac Cryoablation System (includes all BSC commercially available POLARx/POLARx Fit catheters) when used to perform pulmonary vein isolation (PVI) in the ablation treatment of de novo Atrial Fibrillation (AF).
Frequently Asked Questions
What is POLARx Post Approval Study (POLARx PAS)?
POLARx Post Approval Study (POLARx PAS) is a clinical trial registered under NCT06170606. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06170606?
The current status of NCT06170606 (POLARx Post Approval Study (POLARx PAS)) is: ACTIVE_NOT_RECRUITING.
When did POLARx Post Approval Study (POLARx PAS) start?
POLARx Post Approval Study (POLARx PAS) started on 2024-06-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.